Moderna, Inc. (MRNA) NASDAQ
45.72
-1.42(-3.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
45.72
-1.42(-3.01%)
Currency In USD
| Market Cap | 11.47B |
| Enterprise Value | 10.79B |
| P/E Ratio | -6.35 |
| PEG Ratio | -0.28 |
| Price/Sales Ratio | 9.33 |
| Price/Book Ratio | 2.07 |
| Enterprise/Revenue | 8.98 |
| Enterprise/EBITDA | -6.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.45 |
| Operating Margin | -1.58 |
| Return On Assets | -0.23 |
| Return On Equity | -0.3 |
| Revenue | 1.94B |
| Revenue/Share | 4.96 |
| Gross Profit | 1.08B |
| EBITDA | -2.55B |
| Net Income | -2.82B |
| Diluted EPS | -7.26 |
| Total Cash | 5.8B |
| Total Cash/Share | 14.79 |
| Total Debt | 1.92B |
| Total Debt/Equity | 0.22 |
| Current Ratio | 3.29 |
| Book Value Per Share | 22.07 |
| 52-Week Change | 60.2 |
| 52-Week High | 59.55 |
| 52-Week Low | 22.28 |
| Moving Average 50 Days | 51.86 |
| Moving Average 200 Days | 35.56 |
| Average Volume | 8.15M |
| Shares Outstanding | 396.59M |
| % Held by Institutions | 78.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |